Hehlmann R - Search Results

1

Alterations of the cyclin D1/pRb/p16(INK4A) pathway in multiple myeloma.

Krämer A, Schultheis B, Bergmann J, Willer A, Hegenbart U, Ho AD, Goldschmidt H, Hehlmann R. Krämer A, et al. Among authors: hehlmann r. Leukemia. 2002 Sep;16(9):1844-51. doi: 10.1038/sj.leu.2402609. Leukemia. 2002. PMID: 12200702

2

Cyclin A1 is predominantly expressed in hematological malignancies with myeloid differentiation.

Krämer A, Hochhaus A, Saussele S, Reichert A, Willer A, Hehlmann R. Krämer A, et al. Among authors: hehlmann r. Leukemia. 1998 Jun;12(6):893-8. doi: 10.1038/sj.leu.2401051. Leukemia. 1998. PMID: 9639417

3

Analysis of p73 and p53 gene deletions in multiple myeloma.

Schultheis B, Krämer A, Willer A, Hegenbart U, Goldschmidt H, Hehlmann R. Schultheis B, et al. Among authors: hehlmann r. Leukemia. 1999 Dec;13(12):2099-103. doi: 10.1038/sj.leu.2401609. Leukemia. 1999. PMID: 10602435

4

Proliferating status of peripheral blood progenitor cells from patients with BCR/ABL-positive chronic myelogenous leukemia.

Krämer A, Löffler H, Bergmann J, Hochhaus A, Hehlmann R. Krämer A, et al. Among authors: hehlmann r. Leukemia. 2001 Jan;15(1):62-8. doi: 10.1038/sj.leu.2402005. Leukemia. 2001. PMID: 11243401

5

Randomized studies with interferon in chronic myelogenous leukemia (CML) and comparative molecular aspects. German CML Study Group.

Hehlmann R, Willer A, Heimpel H, Hasford J, Kolb HJ, Pralle H, Hossfeld DK, Queisser W, Löffler H, Hochhaus A, Tobler A, Lengfelder E, Berger U, Leib-Mösch C. Hehlmann R, et al. Leukemia. 1997 Apr;11 Suppl 3:506-11. Leukemia. 1997. PMID: 9209440 Clinical Trial.

6

Does long-term culture favor normal clonogenic cells from interferon-treated patients with chronic myelogenous leukemia?

Pasternak G, Schultheis B, Heissig B, Hörner S, Sick C, Hehlmann R. Pasternak G, et al. Among authors: hehlmann r. Leukemia. 1999 Apr;13 Suppl 1:S55-64. doi: 10.1038/sj.leu.2401288. Leukemia. 1999. PMID: 10232367 Review.

7

Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR.

Emig M, Saussele S, Wittor H, Weisser A, Reiter A, Willer A, Berger U, Hehlmann R, Cross NC, Hochhaus A. Emig M, et al. Among authors: hehlmann r. Leukemia. 1999 Nov;13(11):1825-32. doi: 10.1038/sj.leu.2401566. Leukemia. 1999. PMID: 10557058

8

Frequent polymorphism in BCR exon b2 identified in BCR-ABL positive and negative individuals using fluorescent hybridization probes.

Saussele S, Weisser A, Müller MC, Emgi M, La Rosée P, Paschka P, Kuhn C, Willer A, Hehlmann R, Hochhaus A. Saussele S, et al. Among authors: hehlmann r. Leukemia. 2000 Nov;14(11):2006-10. doi: 10.1038/sj.leu.2401929. Leukemia. 2000. PMID: 11069038

9

Therapeutic progress and comparative aspects in chronic myelogenous leukemia (CML): interferon alpha vs. hydroxyurea vs. busulfan and expression of MMTV-related endogenous retroviral sequences in CML. German CML Study Group.

Hehlmann R, Kister P, Willer A, Simon M, Schenk M, Seifarth W, Papakonstantinou G, Saussele S, Kolb HJ, Ansari H, et al. Hehlmann R, et al. Leukemia. 1994 Apr;8 Suppl 1:S127-32. Leukemia. 1994. PMID: 8152279 Review.

10

Expression of interferon regulatory factor (IRF) genes and response to interferon-alpha in chronic myeloid leukaemia.

Hochhaus A, Yan XH, Willer A, Hehlmann R, Gordon MY, Goldman JM, Melo JV. Hochhaus A, et al. Among authors: hehlmann r. Leukemia. 1997 Jul;11(7):933-9. doi: 10.1038/sj.leu.2400723. Leukemia. 1997. PMID: 9204971

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

468 results

Search Page

Filters